Literature DB >> 20726137

The ethical review of health care quality improvement initiatives: findings from the field.

Holly A Taylor1, Peter J Pronovost, Ruth R Faden, Nancy E Kass, Jeremy Sugarman.   

Abstract

Questions have been raised about whether and how health care quality improvement (QI) initiatives ought to be reviewed to address possible ethical issues associated with them. These questions have focused primarily on whether some QI initiatives meet the regulatory criteria for human subject research and should therefore be regulated and reviewed as such. Based on surveys of health care system professionals conducting QI initiatives and hospital CEOs, this issue brief finds that QI initiatives are routinely reviewed by a variety of internal mechanisms prior to implementation, although rarely through an institutional review board or another independent body charged specifically with ethical oversight of QI initiatives. Further research, the authors say, is needed to achieve a better understanding of how review mechanisms for QI initiatives are structured, including information on who reviews these activities, how they are reviewed, and whether such processes include an ethical assessment of the proposed QI initiative.

Entities:  

Mesh:

Year:  2010        PMID: 20726137

Source DB:  PubMed          Journal:  Issue Brief (Commonw Fund)        ISSN: 1558-6847


  6 in total

1.  Clinical practice audit concerning antimicrobial prophylaxis in paediatric neurosurgery: results from a German paediatric oncology unit.

Authors:  Katja Weiss; Arne Simon; Norbert Graf; Jakob Schöpe; Joachim Oertel; Stefan Linsler
Journal:  Childs Nerv Syst       Date:  2016-11-07       Impact factor: 1.475

2.  Oversight on the borderline: Quality improvement and pragmatic research.

Authors:  Jonathan A Finkelstein; Andrew L Brickman; Alexander Capron; Daniel E Ford; Adrijana Gombosev; Sarah M Greene; R Peter Iafrate; Laura Kolaczkowski; Sarah C Pallin; Mark J Pletcher; Karen L Staman; Miguel A Vazquez; Jeremy Sugarman
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

3.  Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.

Authors:  R A Ammann; H J Laws; D Schrey; K Ehlert; O Moser; D Dilloo; U Bode; A Wawer; A Schrauder; G Cario; A Laengler; N Graf; R Furtwängler; A Simon
Journal:  Eur J Pediatr       Date:  2015-03-26       Impact factor: 3.183

4.  Consent Requirements for Testing Health Policies: An Intercontinental Comparison of Expert Opinions.

Authors:  Astrid Berner-Rodoreda; Shannon McMahon; Nir Eyal; Puspita Hossain; Atonu Rabbani; Mrittika Barua; Malabika Sarker; Emmy Metta; Elia Mmbaga; Melkizedeck Leshabari; Daniel Wikler; Till Bärnighausen
Journal:  J Empir Res Hum Res Ethics       Date:  2022-02-10       Impact factor: 1.978

5.  Quality Improvement in Canadian Nephrology: Key Considerations in Ensuring Thoughtful Ethical Oversight.

Authors:  Tamara Glavinovic; Jay Hingwala; Claire Harris
Journal:  Can J Kidney Health Dis       Date:  2022-02-27

6.  Multidrug-resistant bacteria in a paediatric palliative care inpatient unit: results of a one year surveillance.

Authors:  Pia Schmidt; Carola Hasan; Arne Simon; Christine Geffers; Julia Wager; Boris Zernikow
Journal:  GMS Hyg Infect Control       Date:  2020-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.